info: ARRY BOULDER, Colo. (AP) _ Array BioPharma
Post# of 658
Posted On: 11/02/2016 2:30:54 AM
info: ARRY
Quote:
BOULDER, Colo. (AP) _ Array BioPharma Inc. (ARRY) on Tuesday reported a loss of $28.6 million in its fiscal first quarter.
On a per-share basis, the Boulder, Colorado-based company said it had a loss of 20 cents.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The drug developer posted revenue of $39.3 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $37.2 million.
Array BioPharma shares have climbed 35 percent since the beginning of the year. The stock has climbed 11 percent in the last 12 months.
(0)
(0)
my "home" come for a visit here
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone
Scroll down for more posts ▼